Kelly Shi
Stock Analyst at Jefferies
(3.86)
# 1,909
Out of 5,043 analysts
230
Total ratings
44.2%
Success rate
6.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Reiterated: Buy | $35 → $18 | $16.73 | +7.59% | 5 | Oct 6, 2026 | |
| INSM Insmed | Reiterated: Buy | $230 → $219 | $100.60 | +117.69% | 6 | Dec 18, 2025 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $63 → $77 | $64.70 | +19.01% | 13 | Oct 28, 2025 | |
| IMCR Immunocore Holdings | Initiated Coverage: Buy | $48 | $29.39 | n/a | 1 | Aug 24, 2025 | |
| VRDN Viridian Therapeutics | Initiated Coverage: Buy | $44 | $18.66 | n/a | 1 | Aug 24, 2025 | |
| ZLAB Zai Lab | Initiated Coverage: Buy | $52 | $24.99 | n/a | 1 | Aug 24, 2025 | |
| ASND Ascendis Pharma | Reiterated: Buy | $233 → $235 | $229.23 | n/a | 10 | Jul 29, 2025 | |
| COGT Cogent Biosciences | Reiterated: Buy | $20 → $28 | $31.00 | n/a | 5 | Jul 7, 2025 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $59 → $64 | $112.40 | n/a | 6 | Jun 25, 2025 | |
| INCY Incyte | Reiterated: Buy | $75 → $82 | $112.79 | n/a | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $16.99 | n/a | 6 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $8.38 | n/a | 3 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $17.59 | n/a | 9 | May 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $18.62 | n/a | 37 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥5,100 | ¥5,843 | n/a | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $6 | $0.9163 | n/a | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $0.0231 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $30 | $9.86 | n/a | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $42 | $3.89 | n/a | 9 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $286 | $354.47 | n/a | 17 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $40 | $13.33 | n/a | 4 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $10 | $1.73 | n/a | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $11 → $52 | $6.74 | n/a | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $86 | $189.76 | n/a | 4 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $14 | $2.00 | n/a | 2 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $23 | $11.95 | n/a | 2 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $10.82 | n/a | 10 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $7.43 | n/a | 6 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $3.5 | $2.76 | n/a | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $13 | $1.81 | n/a | 6 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $8 | $10.51 | n/a | 5 | Aug 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $6.94 | n/a | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $120 → $7 | $7.67 | n/a | 3 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.00 | $7.36 | n/a | 1 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $6 | $1.74 | n/a | 3 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $14 | $3.16 | n/a | 5 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $5 | $1.40 | n/a | 4 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $1.93 | n/a | 1 | Feb 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $8 | $5.61 | n/a | 4 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.26 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $7 | $0.87 | n/a | 2 | Oct 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $10.30 | n/a | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $23 | $0.4061 | n/a | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $14.10 | n/a | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $53 | $1.46 | n/a | 2 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $4.24 | n/a | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $2.64 | n/a | 1 | Apr 13, 2021 |
ArriVent BioPharma
Oct 6, 2026
Reiterated: Buy
Price Target: $35 → $18
Current: $16.73
Upside: +7.59%
Insmed
Dec 18, 2025
Reiterated: Buy
Price Target: $230 → $219
Current: $100.60
Upside: +117.69%
PTC Therapeutics
Oct 28, 2025
Reiterated: Buy
Price Target: $63 → $77
Current: $64.70
Upside: +19.01%
Immunocore Holdings
Aug 24, 2025
Initiated Coverage: Buy
Price Target: $48
Current: $29.39
Upside: n/a
Viridian Therapeutics
Aug 24, 2025
Initiated Coverage: Buy
Price Target: $44
Current: $18.66
Upside: n/a
Zai Lab
Aug 24, 2025
Initiated Coverage: Buy
Price Target: $52
Current: $24.99
Upside: n/a
Ascendis Pharma
Jul 29, 2025
Reiterated: Buy
Price Target: $233 → $235
Current: $229.23
Upside: n/a
Cogent Biosciences
Jul 7, 2025
Reiterated: Buy
Price Target: $20 → $28
Current: $31.00
Upside: n/a
Kymera Therapeutics
Jun 25, 2025
Reiterated: Buy
Price Target: $59 → $64
Current: $112.40
Upside: n/a
Incyte
Jun 16, 2025
Reiterated: Buy
Price Target: $75 → $82
Current: $112.79
Upside: n/a
Jun 5, 2025
Reiterated: Buy
Price Target: $43
Current: $16.99
Upside: n/a
Jun 4, 2025
Reiterated: Buy
Price Target: $19
Current: $8.38
Upside: n/a
May 31, 2025
Reiterated: Buy
Price Target: $44
Current: $17.59
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $91
Current: $18.62
Upside: n/a
May 8, 2025
Reiterated: Buy
Price Target: ¥5,100
Current: ¥5,843
Upside: n/a
Apr 4, 2025
Reiterated: Buy
Price Target: $24 → $6
Current: $0.9163
Upside: n/a
Mar 25, 2025
Downgraded: Sell
Price Target: $1
Current: $0.0231
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $40 → $30
Current: $9.86
Upside: n/a
Feb 25, 2025
Reiterated: Buy
Price Target: $56 → $42
Current: $3.89
Upside: n/a
Feb 21, 2025
Reiterated: Buy
Price Target: $286
Current: $354.47
Upside: n/a
Feb 10, 2025
Reiterated: Buy
Price Target: $58 → $40
Current: $13.33
Upside: n/a
Jan 21, 2025
Reiterated: Buy
Price Target: $13 → $10
Current: $1.73
Upside: n/a
Jan 7, 2025
Upgraded: Buy
Price Target: $11 → $52
Current: $6.74
Upside: n/a
Dec 20, 2024
Reiterated: Buy
Price Target: $73 → $86
Current: $189.76
Upside: n/a
Dec 16, 2024
Rated: Buy
Price Target: $18 → $14
Current: $2.00
Upside: n/a
Dec 13, 2024
Reiterated: Buy
Price Target: $107 → $23
Current: $11.95
Upside: n/a
Dec 11, 2024
Reiterated: Buy
Price Target: $65
Current: $10.82
Upside: n/a
Nov 18, 2024
Rated: Buy
Price Target: $20
Current: $7.43
Upside: n/a
Nov 15, 2024
Downgraded: Hold
Price Target: $26 → $3.5
Current: $2.76
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: $11 → $13
Current: $1.81
Upside: n/a
Aug 18, 2024
Reiterated: Buy
Price Target: $9 → $8
Current: $10.51
Upside: n/a
Aug 13, 2024
Initiated Coverage: Buy
Price Target: $21
Current: $6.94
Upside: n/a
Jul 19, 2024
Downgraded: Hold
Price Target: $120 → $7
Current: $7.67
Upside: n/a
Jun 10, 2024
Reiterated: Buy
Price Target: $7.00
Current: $7.36
Upside: n/a
Jun 10, 2024
Rated: Buy
Price Target: $15 → $6
Current: $1.74
Upside: n/a
Mar 4, 2024
Reiterated: Buy
Price Target: $11 → $14
Current: $3.16
Upside: n/a
Feb 9, 2024
Reiterated: Buy
Price Target: $75 → $5
Current: $1.40
Upside: n/a
Feb 4, 2024
Initiated Coverage: Buy
Price Target: $36
Current: $1.93
Upside: n/a
Jan 5, 2024
Reiterated: Buy
Price Target: $27 → $8
Current: $5.61
Upside: n/a
Dec 14, 2022
Reiterated: Buy
Price Target: $14
Current: $1.26
Upside: n/a
Oct 5, 2022
Reiterated: Buy
Price Target: $27 → $7
Current: $0.87
Upside: n/a
Aug 15, 2022
Initiated Coverage: Buy
Price Target: $20
Current: $10.30
Upside: n/a
Jan 18, 2022
Rated: Buy
Price Target: $25 → $23
Current: $0.4061
Upside: n/a
Aug 3, 2021
Initiated Coverage: Buy
Price Target: $52
Current: $14.10
Upside: n/a
May 20, 2021
Rated: Buy
Price Target: $53
Current: $1.46
Upside: n/a
Apr 20, 2021
Initiated Coverage: Buy
Price Target: $27
Current: $4.24
Upside: n/a
Apr 13, 2021
Rated: Buy
Price Target: $63
Current: $2.64
Upside: n/a